Cidofovir intravitreous: Began Phase II trial in 90 patients with relapsing CMV retinitis who have progressed despite systemic therapy. Patients will receive a

Gilead Sciences Inc. (GILD), Foster City, Calif. Product: Cidofovir intravitreous Indication: Relapsing cytomegalovirus (CMV) retinitis in AIDS Status: Began Phase II trial in 90 patients with relapsi...